Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,638 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A vasodilating β1 blocker celiprolol inhibits muscular release of uric acid precursor in patients with essential hypertension.
Mizuta E, Utami SB, Ohtahara A, Endo S, Mishima M, Hasegawa A, Yamada K, Kato M, Yamamoto K, Ogino K, Ninomiya H, Miyazaki S, Hamada T, Taniguchi SI, Cheng J, Hisatome I. Mizuta E, et al. Among authors: hamada t. Horm Metab Res. 2013 Jan;45(1):69-73. doi: 10.1055/s-0032-1321872. Epub 2012 Aug 14. Horm Metab Res. 2013. PMID: 22893261 Clinical Trial.
Effect of Antihypertensive Drugs on Uric Acid Metabolism in Patients with Hypertension: Cross-Sectional Cohort Study.
Ueno S, Hamada T, Taniguchi S, Ohtani N, Miyazaki S, Mizuta E, Ohtahara A, Ogino K, Yoshida A, Kuwabara M, Yoshida K, Ninomiya H, Kotake H, Taufiq F, Yamamoto K, Hisatome I. Ueno S, et al. Among authors: hamada t. Drug Res (Stuttg). 2016 Dec;66(12):628-632. doi: 10.1055/s-0042-113183. Epub 2016 Sep 19. Drug Res (Stuttg). 2016. PMID: 27643410
The release of the substrate for xanthine oxidase in hypertensive patients was suppressed by angiotensin converting enzyme inhibitors and alpha1-blockers.
Ohtahara A, Hisatome I, Yamamoto Y, Furuse M, Sonoyama K, Furuse Y, Hamada T, Katoh M, Watanabe M, Kinugawa T, Ogino K, Igawa O, Shimomura T, Murakami F, Yamamoto T, Shigemasa C. Ohtahara A, et al. Among authors: hamada t. J Hypertens. 2001 Mar;19(3 Pt 2):575-82. doi: 10.1097/00004872-200103001-00009. J Hypertens. 2001. PMID: 11327632
Effects of Uric Acid on the NO Production of HUVECs and its Restoration by Urate Lowering Agents.
Mishima M, Hamada T, Maharani N, Ikeda N, Onohara T, Notsu T, Ninomiya H, Miyazaki S, Mizuta E, Sugihara S, Kato M, Ogino K, Kuwabara M, Hirota Y, Yoshida A, Otani N, Anzai N, Hisatome I. Mishima M, et al. Among authors: hamada t. Drug Res (Stuttg). 2016 May;66(5):270-4. doi: 10.1055/s-0035-1569405. Epub 2016 Feb 24. Drug Res (Stuttg). 2016. PMID: 26909689
Effects of a new angiotensin-converting enzyme inhibitor, alacepril, on changes in neurohormonal factors and arterial baroreflex sensitivity in patients with congestive heart failure.
Kinugawa T, Kato M, Mori M, Endo A, Kato T, Hamada T, Noguchi N, Omodani H, Osaki S, Ogino K, Miyakoda H, Hisatome I, Shigemasa C. Kinugawa T, et al. Among authors: hamada t. Eur J Clin Pharmacol. 1998 May;54(3):209-14. doi: 10.1007/s002280050447. Eur J Clin Pharmacol. 1998. PMID: 9681661 Clinical Trial.
2,638 results